Decision is a setback for Dr. Reddy’s Laboratories, which was poised to be one of the first generic competitors to Ozempic ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

Dr Reddy's Labs may face an 8-12 month delay in launching its semaglutide generic in Canada after receiving a non-compliance ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

Danish drugmaker Novo Nordisk on Tuesday cut the price of its blockbuster weight-loss drug, Wegovy, by up to 33% in India, ...

Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

Novo Nordisk cuts Wegovy prices in India by up to 33% to boost access and counter Mounjaro’s growing market lead.

Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk's patent on its branded drugs Ozempic and Wegovy is set to expire in January. "Canada is a major ...

Dr. Reddy's Semaglutide weight-loss drug launch in Canada faces delays due to regulatory compliance issues, impacting share ...

Danish company Novo Nordisk has reduced the price of its weight-loss drug Wegovy by up to 33% in India. The price cuts follow ...

Novo and Lilly are locked in a race for dominance in India, a key battleground for weight-loss treatments in the booming global market, which analysts estimate could be worth $150 billion annually by ...